COVID-19

Here's the roundup of COVID-19 related news from this week.

A session at the American Pharmacists Association 2021 Annual Meeting and Exposition addressed recent immunization practice changes.

In part 2 of our interview, Rich Tremonte of AmerisourceBergen discusses distribution highlights, inspiring efforts from pharmacists, and the future of COVID-19 vaccination.

The FDA has made revisions to the emergency use authorization for the Moderna COVID-19 vaccine.

Here’s an overview of what’s in the late-stage pipeline.

Rich Tremonte from AmerisourceBergen discusses community pharmacy's integral role in the rollout of COVID-19 vaccines and highlights some inspiring stories from community pharmacists.

Here’s a roundup of the latest coronavirus-related news.

The vaccine is 91.3% effective against COVID-19 for up to 6 months after the second dose, according to an analysis of data collected through March 13.

Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.

A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.

A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.

Here’s a roundup of the latest coronavirus-related news.

The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.

A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity

AstraZeneca responded to the concerns by promising to release the most up-to-date data within 48 hours.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.

AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.

The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.

Here’s a roundup of the latest coronavirus-related news.

Survey results suggest independent pharmacies may be better positioned than chains to offer COVID-19 POC testing to their patients.

Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.

Watch this virtual tour of Tulane University's self-care resources website with Patrick Bordnick, dean of the School of Social Work.

Germany, Spain, Ireland, and France, among other EU countries, have decided to temporarily suspend the AstraZeneca COVID-19 vaccine amid reports of serious cases of blood clots.

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves

NCPA lauded the higher reimbursement rate in a statement.